Tools for Targeting High Risk Patients in Your Practice. Statement of Disclosure

Similar documents
Innovations in Clinical Care Delivery Models that Integrate Care Across Settings to Improve Outcomes, Access, and Value

Role of the Clinical Pharmacist in Primary Care

Primary Care Pharmacist Integration and Reimbursement Models

3/17/2017. Innovative Opportunities for Pharmacists in the Evolving World of Healthcare. Elderly represent about of our emergency medical services:

Innovative Opportunities for Pharmacists in the Evolving World of Healthcare

Pharmacy Partnership to Improve Patient Outcomes

USING MTM TO IMPROVE STAR RATINGS : CASE STUDIES

Cost-Effective Process to Improve Drug Adherence for Medicare 5-Star

Population Health Management Design: Optimizing the Outcomes for Special Populations 21th Annual ASHP Conference for Pharmacy Leaders

Medically Complex Older Adults: The Pharmacotherapeutic Challenge

Medication Therapy Management Solution

High ( 50%) Restrictions mg 20-40mg PA; TS ⱡ 15 ⱡ

Overview of Current Quality Measures that can be Impacted by Ambulatory Pharmacists

Improving Medication Adherence through Collaboration between Colleges of Pharmacy and Community Pharmacies

Improving Quality of Care for Medicare Patients: Accountable Care Organizations

Table 1. Proposed Measures for Use in Establishing Quality Performance Standards that ACOs Must Meet for Shared Savings

Quality Care Plus 2015 Primary Care Physician Incentive Program. Now includes Medicare patients!

Capital Health Plan CMS Star Ratings Strategies for Improvement

Prescription Switching and Reduced LDL-C Goal Attainment

PQS Summary of Pharmacy/ Medication-Related Updates in the CY 2020 Final Call Letter

The table below includes the quality measures an ACO is required to submit to CMS as a participant in an MSSP Track 3 ACO

2017 CMS Web Interface Reporting

Medicare Star Ratings and the Shift to Quality- Based Payment Models. David Nau, RPh, PhD, FAPhA PQS President

Medication Therapy Management program

Quality Metrics & Immunizations

2015 Annual Convention

2017 CMS Web Interface Reporting

January 16, Dear Administrator Verma:

Learning Objectives. Patient Case

Florida MEDS-AD Waiver

How to Conduct an Effective Medication Therapy Management Session in the Community Pharmacy

PQRS in TRAKnet 2015 GUIDE TO SUBMIT TING AND REPORTING PQRS IN 2015 THROUGH TRAKNET

Medicare Shared Savings Program Quality Measure Benchmarks for the 2014 and 2015 Reporting Years

It takes a Village: Medication Management Partnering with patients to optimize medication outcomes

Sect S io ecn ti 1 o : n Trend 1: Tres nds

9/25/15. Pharmacy Quality Measures: Financial Support. Learning Objectives. Speaker Disclosure. Access to Preferred Networks and Clinical Performance

Provider Perspective of Quality Measurement

Bob Davis, PharmD, FAPhA Professor and Chair, KPIC South Carolina Primary Health Care Association September 19, 2015

REVIEW AND FREQUENTLY ASKED QUESTIONS (FAQ) 8/5/2015. Outline. Navigating the DSMT Reimbursement Maze in Todays Changing Environment

Conflict of Interest Disclosure. Learning Objectives. Learning Objectives. Guidelines. Update on Lifestyle Guidelines

Safe, effective, affordable drug choices: online tool for payers and patients.

Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center

LIPITOR AND YOU HELPFUL INFORMATION FOR UNDERSTANDING CHOLESTEROL AND RISKS

2013 Hypertension Measure Group Patient Visit Form

Learning Objectives. Collaborative Medication Management (MTM) Programs: Successful Outcomes. Collaborative Drug Therapy Management (CDMT)

7:30 a.m. 8:05 a.m. Welcome/Introductions and Tips for Success

New Approach to Reducing Adverse Drug Events Anticoagulants Insulin Opioids

Disclosure. Learning Objectives 6/4/2014. Medication Adherence: Challenges and Opportunities

Issues for Part D Compliance

Economics of Reducing Out-of-Pocket Costs for Cardiovascular Preventive Services for Patients with High Blood Pressure and High Cholesterol

Lloydminster Community Cancer Centre Patient Guide for Cancer Care

HEADED FOR HEDIS AND REACHING FOR THE STARS: THE PHARMACIST S ROLE IN POPULATION HEALTH MANAGEMENT

Case Studies The Role of Non-Statin Therapies for LDL-C Lowering in the Management of ASCVD Risk

A Step-by-Step Guide for Rubicon Pharmacists Delivering the RubiReview Program (SMAP)

Adverse Drug Events Impact on Hospital Readmissions

Fort McMurray Community Cancer Centre Patient Guide for Cancer Care

Value Based Pay for Performance Results & Highlights Measurement Year September 2017

PCMH 2018 Enrollment and Update August 25, 2017

Understanding Your Patient Care Opportunity Report (PCOR)

MU - Selection & Configuration of Measures

NEWSLETTER DUE CARE PROGRAM. WINTER 2014 Summer 2015 COMMONLY ASKED QUESTION:

Module 6. Pharmacy Based Respiratory Therapy Services. Scott K. Stolte, Pharm.D. Pre-Assessment Exercise

STARS SYSTEM 5 CATEGORIES

When Statins Aren t Enough: Appropriate Therapies for High-Risk Patients with Diabetes

Medication Therapy Management: Improving Health and Saving Money

Back to Basics: The Basics of Medication Monitoring

ATP IV: Predicting Guideline Updates

Jae Jin An, Ph.D. Michael B. Nichol, Ph.D.

Managing Pharmacy Expenses in PACE: A Case Based Discussion. Valencia P. Covington, MD, MPH Jennifer Keller, PharmD, BCPS, CGP June 5, 2016

Advances in Alignment, Measurement, and Performance MY 2017 Results Highlights

How pharmacy and retail health can support health and wellness. Nancy Gagliano Chief Medical Officer, MC September, 2014

CHI Franciscan. Matt Levi Director Virtual Health Services. March 31, 2015

Lead the Way with Advanced Care Management. Workbook

Cost-Motivated Treatment Changes in Commercial Claims:

Medicare Advantage Measurement Period Handbook for Enhanced Personal Health Care Measurement Period beginning January 1, 2015

BETTER WAYS TO PAY FOR CANCER CARE Creating Win-Win-Win Approaches for Oncologists, Cancer Patients, and Payers

Florida MEDS-AD Waiver

What to Expect Today. Example Study: Statin Letter Intervention. ! Review biostatistic principles. ! Hands on application

LEARNING & SHARING SESSION: BEST PRACTICES IN COMPREHENSIVE DIABETIC CARE AND PATIENT ENGAGEMENT. December 2017

2014 ACO GPRO Audit What this means for your practice. Sheree M. Arnold ACO Clinical Transformation Specialist

Medicare Shared Savings Program Accountable Care Organization (ACO) Measure Deep Dive Series

A&M Care Prescription Drug Program Express Scripts Holding Company. All Rights Reserved.

Achieving Quality and Value in Chronic Care Management

Reducing COPD Exacerbation Readmissions in a Community-Based Teaching Hospital

HEALTHCARE REFORM. September 2012

2019 HEDIS 1 Measures Healthcare Effectiveness Data and Information Set

Statement Of. The National Association of Chain Drug Stores. For. U.S. House of Representatives Committee on the Budget.

Diabetes Audit Results, Portland Area, Site-Specific Trends

Statement Of. The National Association of Chain Drug Stores. For. U.S. Senate Finance Committee. Hearing on:

Hae Sun Suh, B.Pharm., Ph.D. Jason N. Doctor, Ph.D.

Placebo-Controlled Statin Trials

Pharmacy Coverage Guidelines are subject to change as new information becomes available.

It takes a village: How ACO s can partner with hospitals and community pharmacists to improve care transitions.

Conflicts of interest. What's the Skinny on the Lipid Guidelines? Key Differences. Are you applying the new ACC/AHA Lipid guidelines in your practice?

Management of Novel Oral Anticoagulants (NOACs) with the DAWN AC modules

Comprehensive Treatment for Dyslipidemias. Eric L. Pacini, MD Oregon Cardiology 2012 Cardiovascular Symposium

Placebo-Controlled Statin Trials Prevention Of CVD in Women"

PLEASE FILL OUT & RETURN

The University of Mississippi School of Pharmacy

New Mexico Retiree Health Care Authority Medicare Part D Prescription Drug Program Express Scripts Holding Company. All Rights Reserved.

Transcription:

Tools for Targeting High Risk Patients in Your Practice Joseph Vande Griend, PharmD, BCPS, CGP Assistant Professor, University of Colorado Departments of Clinical Pharmacy and Family Medicine Skaggs School of Pharmacy and Pharmaceutical Sciences Statement of Disclosure I have no relevant financial relationships with commercial interests pertaining to the content presented in this program.

Background information about me Experience and current activity in pharmacy Current faculty position Clinical practice Seniors Clinic, Family Medicine Research interests Service Learning Objectives 1. Describe the development and application of the Clinical Pharmacy Priority (CP2) Score tool to the practice of clinical pharmacy 2. Identify patients in your inpatient or outpatient pharmacy practice that would most benefit from more intensive pharmacist-provided medication review 3. Develop your own system of prioritizing patients in your pharmacy practice in order to most effectively and efficiently provide a high level of pharmacy care

Why is this important? Pharmacists are expensive! $75 per hour considering salary + benefits We want to provide the best care we can for the most patients given the resources available The healthcare system cares about it and is moving towards evaluating it - Patient-Centered Medical Home - Accountable Care Organizations A move in healthcare away from fee-for-service and towards improved outcomes and reduced cost. A provider, clinic, or organization that is accountable for the care of a large group of patients, and outcomes related to optimal care are documented and tracked with the goal of improving.

CMS: Medicare Plan Evaluation Star Ratings Annual rating of Medicare plans available on Medicare Plan Finder on CMS web site. Ratings displayed as 1-5 stars = poor performance = below average performance = average performance = above average performance = excellent performance http://www.cms.gov/medicare/prescription-drug- Coverage/PrescriptionDrugCovGenIn/index.html?redirect=/PrescriptionDrugCovGenIn/06_PerformanceData.asp CMS: Medicare Plan Evaluation Star Ratings Medicare Prescription Drug Plans are evaluated using a variety of different measures Example measures: Medication adherence: statins, blood pressure, oral diabetes medications High risk medication in the elderly Appropriate treatment of blood pressure in a patient with diabetes Achievement of these measures can lead to enhanced payment from CMS for the Medicare drug plan

Pharmacy Quality Alliance Mission Statement: Improve the quality of medication management and use across health care settings with the goal of improving patients health through a collaborative process to develop and implement performance measures and recognize examples of exceptional pharmacy quality. Example measures: 1. Type 2 diabetes mellitus Percent of patients age 18-75 years with A1c > 9% Percent of patients age 18-75 years with LDL < 100 mg/dl Percent of patients age 18-75 years with BP < 140/90 2. Adherence to non-warfarin anticoagulants Percent of patients aged > 18 years who had > 80% proportion of days covered for dabigatran, rivaroxaban, apixaban CMS and Medication Therapy Management Targeted beneficiaries for an MTM program (2014) 1. Chronic disease states a. Alzheimer s, chronic heart failure, diabetes, dyslipidemia, ESRD, HTN, Asthma, COPD, osteoporosis, osteoarthritis, mental health 2. Multiple medications a. Minimum requirement for MTM program is 2-8 medications 3. The cost of Part D covered drugs > $3,017 http://www.cms.gov/medicare/prescription-drug-coverage/prescriptiondrugcovcontra/downloads/memo- Contract-Year-2014-Medication-Therapy-Management-MTM-Program-Submission-v040513.pdf

Think, Pair, Share Individually come up with 3-5 patient-specific factors that you believe will help target high risk patients in your setting Then team up with someone who works in the same setting and discuss your factors We will then share lists with the entire audience CP2 Score Background Offsite Clinical Pharmacy Service July 2011: CU Park Meadows Family Medicine Prospective clinical pharmacy medication review 1-year results 315 recommendations, ~ 70% accepted, 118 hours pharmacist time 49 vaccinations administered, ~ $50,000 estimated annual savings due to discontinuation of high-cost drugs Accepted in Family Medicine August 2012: Expansion CU Boulder Family Medicine Efficiency needed to better identify patients who benefit

Objectives CP2 Score 1. To develop a tool that would facilitate the prioritization of patients for comprehensive medication review (CMR) by a clinical pharmacist in family medicine 2. To evaluate the tool to determine if those with a higher score are more likely to receive a medication recommendation than those with a low score after clinical pharmacist CMR. Methods The CP2 Score was developed by the research team programmed into the EPIC electronic medical record using ICD-9 codes and patient-specific data A cross-section of the upcoming week s appointments with prioritized scores is generated each Friday From 10/5/2012 through 12/18/2012 (11 weeks), 75% of patients with appointments received CMR For each given day of appointments, the clinical pharmacist either reviewed all patients, or did not provide any review. There was no specific pattern when evaluating which appointment day of the week no medication reviews were performed.

Methods/Results A CP2 Score was calculated on all patients 1. Those receiving a medication a recommendation from October 5, 2012 through December 18, 2012, and those who received a prior recommendation since July 2011. 2. Those receiving no medication recommendation after CMR 1,107 charts were reviewed 1,006 did not receive a medication recommendation 101 patients were identified as having received a recommendation after CMR N = 54 during the timeframe N = 47 a prior recommendation after prospective CMR CP2 Score (range: 0-21 points) Example Criteria* Chronic Disease Diagnosis - e.g., Diabetes, HTN, vascular disease Age (years) Objective patient data including lab values/vitals Number of items on the medication list *Point allocation was developed based on several iterations by investigators. The process of validating this tool is ongoing.

Medication recommendation after CMR CP2 Score Total reviewed Recommendation Yes No 0 290 0 290 0 1 178 1 177 0.6 2 120 1 119 0.8 3 73 3 70 4.1 4 91 8 83 8.8 5 75 7 68 9.3 6 58 11 47 19 7 61 8 53 13.1 8 56 16 40 28.6 9 45 17 28 37.8 10 18 7 11 38.9 11 15 8 7 53.3 12 14 8 6 57.1 13 8 2 6 25 14 3 2 1 66.7 15 2 2 0 100 - There were no patients with a score of 16 or higher *Chi-square = 236, DF = 3, p < 0.0001 % *2/588 (0.3%) *37/358 (10.3%) *40/119 (33.6%) *22/42 (52.4%) Sample of Drug Therapy Problems (DTPs) with recommendations DTPs (n) Common recommendation (n) Needs additional therapy (118) Vaccine (62) Statin (31) BP agent (6) Antidiabetic (4) Unnecessary drug (31) ER niacin, ezetimibe (10) TG lowering agent (7) Wrong dose (24) BP drug dose too high/low (17) DM drug dose to high/low (3) Cost (13) Brand to alternate generic (8) Inappropriate drug (10) Unsafe in elderly (10) 132 of 223 recommendations accepted (59.2%)

Conclusions Patients with higher CP2 scores were more likely to get a medication recommendation after CMR than patients with lower CP2 scores. The CP2 Score could be utilized in family medicine and other ambulatory care practices to help clinical pharmacists prospectively identify patients who are likely to benefit from CMR. What are the limitations of using something like a CP2 Score in your practice?

Ideas to Consider (Community Pharmacy) Simvastatin interactions Prospectively identify all relevant interacting drugs (e.g. all simvastatin 40mg + amlodipine) Contact providers Choose method of communication Be prepared to provide alternatives May require laboratory data, formulary data Case Example: 58 yo male on simvastatin 40mg + dilt CD 240mg Insurance covers Atorvastatin at same co-pay Ideas to Consider (Community Pharmacy) Target all drugs with co-pay $50 or more Patients have a significant incentive to want your input Savings impact can be substantial Prescribers often willing to listen Will require knowledge of drug formulary to provide the most effect

Ideas to Consider (Community Pharmacy) Adherence program Autofill Generate report of patients who are 60 days past due Incorporate students into the program Intensive counseling All injectables, high risk drugs Ideas to Consider (Community Pharmacy) Pneumonia vaccine A CMS Star measure Pull all patients who filled a diabetes medication in the last 1-3 months and all those > 65 years Contact each patient over the phone, screen for vaccine need, and set up app t

Ideas to Consider (Primary Care Clinic) Unnecessary lipid-lowering agents Pull all patients with Niaspan, Lovaza, gemfibrozil, fenofibrate, Zetia Review medical record for indication Place note in medical record Significant cost implications Each stopped med can save $1000 per year High Risk Drugs Based On ED Hospitalizations (Any setting) Emergency Hospitalizations for Adverse Drug Events in Older Americans 5,077 cases (99,628 emergency hospitalizations) for adverse drug events in adults 65 years yearly from 2007-2009 Nearly 2/3 were in patients 80 years or older 4 medications/classes implicated in 2/3 of events Warfarin (33%) Insulins (13.9%) Oral antiplatelet agents (13.3%) Oral hypoglycemic agents (10.7%) NEJM 2011; 365: 2002-12

Ideas to Consider (Long-term Care) Monthly medication review Already required for all patients in long-term care All patients in long-term care are complex, but some may be more complex Focus more on those with a high risk medication, those on opioid therapy, or those with diabetes Ideas to Consider (Hospital setting) What are those areas where you can save money or improve care? Medication reconciliation Any patient hospitalized due to an adverse drug event Targeting high cost medication

Develop your own system It does not have to be complex Minute paper Identify one or two strategies or ideas that you will put into practice starting next week. What are you currently doing, what have you done to focus on a higher risk patient, or what are you planning to do?